New biomarker can help identify people with a primary tauopathy


Zooming in on a single disease and studying it intensely is often the most productive route to finding treatments. But there’s no easy way to distinguish among people living with any of the primary tauopathies -; a group of rare brain diseases marked by rapidly worsening problems with thinking and movement -; because the symptoms are too similar.

Ayahuasca: Just how safe is this psychoactive brew?

Previous article

Scientists develop 20-subtype mRNA flu vaccine to protect against future flu pandemics

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News